Cell therapy expert Lindsay Davies, PhD, FHEA, discusses the key considerations for moving the needle to broader adoption of CGTs in Europe.

The development of cell and gene therapies (CGTs) is a dynamic and evolving area, challenging technology,…
Cell therapy expert Lindsay Davies, PhD, FHEA, discusses the key considerations for moving the needle to broader adoption of CGTs in Europe.
The development of cell and gene therapies (CGTs) is a dynamic and evolving area, challenging technology,…